| 0000-00-00 |
|
|
|
External link to document |
| 2022-11-04 |
147 |
Letter |
ordering Avadel to submit a patent certification for Jazz’s U.S. Patent No.
8,731,963. During that hearing, …relief—namely, the ongoing, statutorily prescribed patent
infringement and counterclaim proceedings in the… 4 August 2021
1:21-cv-01138
830 Patent
None
District Court, D. Delaware
|
External link to document |
| 2022-11-18 |
151 |
Opinion - Memorandum Opinion |
alleges infringement of U.S. Patent Nos.
8,731,963 ("the '963 patent"), 10,758,488 ("…quot;the ' 488 patent"), 10,813 ,885 ("the ' 885 patent"),
10,959,956 ("the…;the ' 956 patent"), 10,966,931 ("the ' 931 patent"), 11 ,077,079 ("the …the ' 079 patent"),
and 11,147,782 ("the '782 patent"). 1 Before the Court is …quot; It is a bedrock principle of patent law that the claims of a patent define the invention to
which |
External link to document |
| 2023-01-05 |
179 |
Redacted Document |
discovery related to Jazz’s U.S. Patent No. 8,731,963 (the “REMS System
Patent”) (D.I. 276). In its request…System
Patent regardless of the outcome of its appeal. As Jazz explained, the REMS System Patent
“expired…infringement or validity of the [REMS System Patent] from
either a patent or regulatory law perspective.” (D.I…Request to Stay Expert Discovery Related to the '963 Patent by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals… STAY EXPERT DISCOVERY RELATED TO THE ’963 PATENT
ME1 43841951v.1
Case 1:21-cv-01138-GBW Document |
External link to document |
| 2023-01-18 |
182 |
Notice of Service |
Kevin C. Almeroth Regarding Patent Ineligibility of U.S. Patent No. 8,731,963, (3) Opening Expert Report…Jeffrey Gudin Regarding Invalidity of U.S. Patent 8,731,963, (9) Expert Report of Dr. Martin Scharf, and… 4 August 2021
1:21-cv-01138
830 Patent
Both
District Court, D. Delaware
|
External link to document |
| 2024-03-04 |
462 |
Redacted Document |
an Avadel patent application, No. 10/826,690
(Ex. 3) that issued as U.S. Patent No. 8,101,209 on its proprietary…in this case. Rather, the Court found
“that the patent cases and the trade secrets case do not share enough…support for Avadel’s argument here that Jazz’s patents
are invalid for failing to name true inventors,…to Jazz on Invalidity of the
Sustained Release Patents for Improper Inventorship” and is not a separate…issues;
Avadel will be asking the jury to decide patent invalidity based on improper inventorship. Avadel |
External link to document |
| 2022-08-09 |
90 |
Letter |
delisting counterclaim related to U.S. Patent 8,731,963
(the “’963 Patent”). D.I. 55, 56.
Despite …regarding the scope of the ’963 Patent’s claims, whether the ’963 Patent is
appropriately listed in the…Procedure
Act related to Jazz’s listing of the ’963 Patent in the Orange Book, and the FDA’s related
determination…determination that Avadel must certify against that patent in connection with its 505(b)(2) New
Drug Application…Book, the scope of Jazz’s listing code for that patent, and how
Avadel’s accused product compares to that |
External link to document |
